U.S. FDA Woes Continue For Lupin
An employee collects Pentalgin tablets from a storage bin at a drug manufacturing unit in Kursk, Russia. (Photographer: Andrey Rudakov/Bloomberg)

U.S. FDA Woes Continue For Lupin

The U.S. regulator barred Lupin Ltd.’s Mandideep, Madhya Pradesh facility from getting new approvals for exporting to the U.S.—its largest market—on the back of manufacturing practices concerns.The...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.